What's Happening?
Oak Ridge National Laboratory (ORNL) has implemented a significant change in its chemical separation process for Californium-252 (Cf-252), a critical neutron source. The lab, which is the sole producer of Cf-252 for the Western world, announced an update
to its chemistry that reduces the separation time by approximately one week, effectively halving the duration of this crucial step. This improvement involves swapping a molecule in the separation process, allowing for the removal of 95 percent of unwanted isotopes like americium, curium, and cerium in a single cycle. Previously, the process required reducing the acidity of the solution, a step that alone took about a week. The new method, developed by ORNL radiochemist Laetitia Delmau, utilizes a neutral molecule that can function in the existing nitric acid solution, eliminating the need for this time-consuming adjustment. This advancement is particularly impactful as the separation occurs within a shielded hot cell, an extremely expensive environment to operate.
Why It's Important?
This accelerated production of Californium-252 is vital for several U.S. industries and strategic initiatives. Cf-252 is essential for starting new nuclear reactors, with federal policy pushing for the construction of 10 new large reactors by 2030 and 5 gigawatts of power uprates at existing plants. Additionally, the U.S. Army is mandated to have a reactor operating on a domestic military base by September 30, 2028, all of which will rely on ORNL's Cf-252. Beyond reactor startups, Cf-252 is used in fuel rod scanners, port security, coal analysis, oil well logging, and instrument calibration. The reduction in processing time translates directly into cost savings due to fewer hot cell hours, a critical factor given the high operational expenses of these facilities. This efficiency gain helps meet increasing demand and strengthens the domestic supply chain for this indispensable radioisotope, reducing potential vulnerabilities associated with a single-source producer.
What's Next?
The new chemical process is slated for full implementation in the next Cf-252 production campaign, scheduled for 2027. While ORNL runs these campaigns every two years, the enhanced efficiency of the separation process will allow the lab to process curium targets more effectively within the existing schedule. The High Flux Isotope Reactor (HFIR) at Oak Ridge, which produces the curium targets, recently concluded Cycle 516B and is scheduled to begin Cycle 517 soon. The improved chemistry will enable ORNL to meet the growing demand for Cf-252 from various sectors, including new small fission reactor companies and established customers. The lab is also exploring other avenues to increase output, such as more frequent reactor cycles with curium targets, to further address the rising demand for this critical material.
Beyond the Headlines
The development at ORNL highlights a broader strategic challenge for the U.S. in maintaining a robust domestic supply of critical isotopes. The reliance on a single facility for Cf-252 production mirrors similar single-source dependencies for medical isotopes, underscoring potential vulnerabilities in national infrastructure. The economic argument for saving time in hot cell operations, even without a specific dollar figure, points to the immense costs associated with handling highly radioactive materials and the value of scientific innovation in mitigating these expenses. Furthermore, the meticulous process of transforming Cf-252 into a usable wire, involving techniques akin to jewelry making, illustrates the specialized and precise nature of nuclear material handling. This advancement not only addresses immediate demand but also contributes to the long-term resilience and self-sufficiency of the U.S. in critical nuclear technologies and applications.
